Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group
- 1 August 2005
- journal article
- clinical trial
- Published by Wiley in European Journal of Haematology
- Vol. 75 (2), 124-129
- https://doi.org/10.1111/j.1600-0609.2005.00482.x
Abstract
To investigate the efficacy and toxicity of the combination of gemcitabine and vinorelbine in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBL), 22 patients with relapsed or refractory DLBL were treated with gemcitabine 1000 mg/m2 and vinorelbine 30 mg/m2 on days 1 and 8 every 3 wk for a maximum of six cycles. Fourteen patients were considered chemosensitive while eight patients were considered chemoresistant to the last treatment regimen. All 22 patients were assessed for response to treatment. Three patients (14%) achieved complete remission and eight patients (36%) had partial remission of their disease, with an overall response rate of 50%. With a median follow up of 44 months, the median time to progression (TTP) for all patients was 8.1 months while the median overall survival (OS) was 12.9 months. Toxicity was minimal and all patients were treated on an outpatient basis. The combination of gemcitabine and vinorelbine is an effective and well-tolerated regimen for patients with relapsed of refractory DLBL.Keywords
This publication has 24 references indexed in Scilit:
- Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphomaCancer, 2004
- Gemcitabine and Cisplatin in Refractory Malignant LymphomaOncology, 2004
- Rituximab-Mediated Sensitization of B-Non-Hodgkin's Lymphoma (NHL) to Cytotoxicity Induced by Paclitaxel, Gemcitabine, and VinorelbineCancer Biotherapy & Radiopharmaceuticals, 2002
- Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinomaCancer, 2000
- Infusional Vinorelbine in Relapsed or Refractory LymphomasLeukemia & Lymphoma, 2000
- Introduction to the WHO ClassificationThe American Journal of Surgical Pathology, 1997
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993
- Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInternational Journal of Cancer, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958